International Pediatric Otolaryngology Group: Consensus guidelines on the diagnosis and management of type I laryngeal clefts
Jeffrey C. Yeung(Boston Children's Hospital), Reza Rahbar(Boston Children's Hospital), Bryan J. Liming(University of Iowa Hospitals and Clinics), Marlene Soma(Sydney Children's Hospital), Karen B. Zur(Children's Hospital of Philadelphia), Alan Cheng(The University of Sydney), Karthik Balakrishnan(Mayo Clinic), Dana M. Thompson(Lurie Children's Hospital), Éric Moreddu(Assistance Publique Hôpitaux de Marseille), Douglas R. Sidell(Lucile Packard Children's Hospital), George H. Zalzal(Children's National), John Russell(Children's Health Ireland at Crumlin), Briac Thierry(Hôpital Necker-Enfants Malades), Jean‐Michel Triglia(Hôpital de la Timone), Catherine K. Hart(Cincinnati Children's Hospital Medical Center), Jorge Spratley(Universidade do Porto), Michael J. Rutter(Cincinnati Children's Hospital Medical Center), Nicolas Leboulanger(Hôpital Necker-Enfants Malades), Andrew F. Inglis(Seattle Children's Hospital), Eréa‐Noël Garabédian(Délégation Paris 5), Karen Watters(Boston Children's Hospital), Sam J. Daniel(Montreal Children's Hospital), R. Nicollas(Hôpital de la Timone)
Cited by 48
Related Papers
Clinical Practice Guideline: Hoarseness (Dysphonia)
|Otolaryngology|2009|446
Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma
|International Journal of Pediatric Otorhinolaryngology|2009|235
A Prospective Study of the Incidence of Juvenile-Onset Recurrent Respiratory Papillomatosis After Implementation of a National HPV Vaccination Program
|The Journal of Infectious Diseases|2017|145
Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30‐year nationwide cohort of 1478 patients under 18 years of age
|British Journal of Haematology|2016|130
Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: A preliminary retrospective study of French experience
|International Journal of Pediatric Otorhinolaryngology|2010|110